QGEN Earnings & Financial Statements
Qiagen N.V.
$45.38
+$0.85(+1.91%)
63
Overall
80
Value
63
Tech
47
Quality
Market Cap
$9.35B
Volume
1.26M
52W Range
$32.53 - $57.82
Target Price
$45.40
QGEN earnings and financial statements: Qiagen N.V.'s income statement, balance sheet and cash flow statement, annual and quarterly.
QGEN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.09B | $1.98B | $1.97B | $2.14B | $2.25B |
| Cost of revenue | $790.50M | $1.01B | $667.42M | $756.96M | $800.84M |
| Operating income | $520.31M | $199.90M | $445.25M | $531.46M | $1.36B |
| EBITDA | $720.63M | $386.68M | $718.72M | $779.36M | $895.24M |
| Net income | $424.88M | $83.59M | $341.30M | $423.21M | $512.60M |
| EPS (diluted) | $1.94 | $0.37 | $1.48 | $1.84 | $2.21 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $6.28B | $5.69B | $6.12B | $6.29B | $6.15B |
| Total liabilities | $2.50B | -$13.18B | $2.31B | $2.82B | $3.05B |
| Shareholders’ equity | $3.78B | $3.57B | $3.81B | $3.47B | $3.10B |
| Cash and equivalents | $839.00M | $663.55M | $668.08M | $122.31M | $880.52M |
| Long-term debt | $1.65B | -$8.40B | $921.82M | $1.47B | $1.09B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $654.33M | $673.55M | $459.45M | $715.26M | $639.00M |
| Capital expenditure | - | - | - | -$149.32M | -$206.50M |
| Free cash flow | $447.20M | $502.31M | $296.65M | $565.94M | $432.50M |
| Dividends paid | $54.24M | - | - | - | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | QGEN | $45.38 | +1.9% | 1.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |